Gopal Krishan Aggarwal
About Gopal Krishan Aggarwal
Data last updated:
Gopal Krishan Aggarwal has 29 years in corporate governance. Holds Director role. Currently with 1 company, including Plantoid Medix Private Limited and Astralix Life Sciences Private Limited. Formerly with 3 companies, such as P.P. Medical Impex Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Plantoid Medix Private Limited U01113DL2019PTC352488 | Director | 21 Apr 2022 | 2019 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| P.P. Medical Impex Private Limited U74899DL1993PTC053146 | Director | 25 Nov 2004 | 1993 | Strike Off |
| Astralix Life Sciences Private Limited U85121DL2006PTC153131 | Director | 10 May 2008 | 2006 | Strike Off |
| G.K.Biotec Surgicals Private Limited U33112DL1997PTC084660 | Director | 24 Jan 1997 | 1997 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gopal Krishan Aggarwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gopal Krishan Aggarwal
Gopal Krishan Aggarwal has 29 years in corporate governance. Holds Director role. Currently with 1 company, including Plantoid Medix Private Limited and Astralix Life Sciences Private Limited. Formerly with 3 companies, such as P.P. Medical Impex Private Limited. Engaged in General Business. Contributes to corporate operations.
Gopal Krishan Aggarwal is associated with 1 company as Director.
Gopal Krishan Aggarwal has expertise in General Business.
Gopal Krishan Aggarwal has 29 years in corporate governance.